AdExchanger’s Top 10 (Or 16) Most Popular Opinion Columns Of 2024
2024’s most popular guest columns offer a snapshot of an industry in flux – and one that’s grown cynical due to repeated promises of unrealized change.
2024’s most popular guest columns offer a snapshot of an industry in flux – and one that’s grown cynical due to repeated promises of unrealized change.
“Standard advertising services” shouldn’t include recording intimate patient-doctor conversations to help drug companies guide doctors on how to push opioids.
In today’s newsletter: The FTC is suing Kochava (again); marketers are complacent about third-party cookie deprecation; and Publicis Health pays the piper for its role in the opioid epidemic.